# Semaglutide vs Exenatide: How They Differ | PepVault

Source: https://pepvault.app/peptides/compare/semaglutide-vs-exenatide

Last updated: 2026-11-18

Use: © PepVault. Read and cite with a link. Copying, bulk scraping, rewriting or republishing is not permitted (https://pepvault.app/terms#content).

[Library](https://pepvault.app/peptides) [Comparisons](https://pepvault.app/peptides/compare) Semaglutide vs Exenatide

Compared side by side

# Semaglutide vs exenatide: how they differ

Reviewed November 2026 [How we check the library](https://pepvault.app/about#library) [Published by PepVault](https://pepvault.app/guides/how-we-research)

## The short answer

Both are GLP-1 receptor agonists, and exenatide, a copy of exendin-4 from Gila monster venom, was the first approved; with a half-life of about 2.4 hours it is a shot before the two main meals, while semaglutide lasts about a week and is taken weekly. Exenatide was FDA-approved in 2005, as Byetta, for blood sugar control in type 2 diabetes, and its US products are being discontinued; semaglutide is FDA-approved for type 2 diabetes and weight management, as Ozempic and Wegovy. Exenatide’s effect on weight was about 3 kg in its 24- to 30-week trials, and semaglutide averaged about 15% weight loss at 68 weeks in its main trial.

## Side by side

| Compared | [Semaglutide](https://pepvault.app/peptides/semaglutide) | [Exenatide](https://pepvault.app/peptides/exenatide) |
| --- | --- | --- |
| Category | Metabolic & GLP-1 | Metabolic & GLP-1 |
| Also known as | Ozempic, Wegovy | Byetta, Exendin-4, AC2993 |
| What it is | A GLP-1 receptor agonist that mimics a gut hormone your body releases after eating: it reduces appetite and slows stomach emptying. | The first GLP-1 drug, made from a peptide found in Gila monster venom, approved in 2005 as Byetta for type 2 diabetes: a shot before breakfast and dinner that lowers blood sugar after meals. |
| How it works | GLP-1 receptor agonist that reduces appetite, slows gastric emptying, and improves glucose metabolism. FDA-approved for T2DM and obesity. Titrate dose slowly to minimize GI side effects. | The first GLP-1 receptor agonist approved: a synthetic copy of exendin-4, a 39-amino-acid peptide first found in the venom of the Gila monster, whose sequence partly overlaps human GLP-1. It releases insulin when glucose is high, lowers glucagon and slows stomach emptying, and it reduces food intake. It is cleared by the kidneys with a half-life of about 2.4 hours, so the original form (Byetta) is a shot before the two main meals of the day. FDA-approved in 2005 for type 2 diabetes in adults; it is not approved for weight management, and every US exenatide product is now listed as discontinued. |
| Commonly reported | The constant background thoughts about food ("food noise") go quiet and portions shrink without effort, with nausea worst in the first days after each dose step. FDA-approved for type 2 diabetes, weight management, heart-risk reduction and MASH, with about 15% average weight loss at 68 weeks in its main trial. | A smaller appetite and nausea in the first weeks, easing for most people with time. Every US exenatide product, including the weekly Bydureon BCise, is now listed by the FDA as discontinued. |
| Studied range | FDA label: 0.25–2.4 mg, starting dose 0.25 mg. | FDA label: 5–10 mcg, starting dose 5 mcg. |
| How often | Weekly SubQ | Twice daily SubQ, before meals |
| Half-life | ~1 week (FDA label) | ~2.4 hours (FDA label) |
| Route | SubQ injection | SubQ injection |
| Typical run | FDA-approved for ongoing use. Community uses indefinitely or until goal weight reached, then tapers. | FDA-approved for ongoing use in type 2 diabetes; the label's trials ran 16 to 30 weeks, with open-label extensions to 52 weeks. The once-weekly extended-release form (Bydureon, later Bydureon BCise) was studied for a median of 3.2 years in EXSCEL. |
| Evidence | Established: clinical trials or FDA-approved use exists | Established: clinical trials or FDA-approved use exists |
| Common side effects | Nausea, vomiting, diarrhea, constipation, decreased appetite, fatigue, pancreatitis risk | Nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, indigestion, low blood sugar (with a sulfonylurea or insulin) |

Typical run: Community practice — opinions vary. Not a clinical recommendation.

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking semaglutide or exenatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-flow&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## Week by week

Each entry’s cards by day window, as the compound pages show them. Day 1 is the day you start it.

### Semaglutide

- Day 1–28 · 0.25 mg Gut is adapting
- Day 29–56 · 0.5 mg Appetite shifts are real now
- Day 57–112 · 1 mg Clinically useful weight loss kicks in
- Day 113–140 · 1.7 mg Max submaximal step
- Day 141–364 · 2.4 mg Full dose — the working dose
- Day 365+ Plateau territory — new baseline

[Every card for semaglutide, with its sources](https://pepvault.app/peptides/semaglutide#weeks)

### Exenatide

- Day 1–30 · 5 mcg The 5 mcg start, before two meals
- Day 1–60 Why the shot comes before the meal
- Day 31–180 · 10 mcg 10 mcg, the full dose
- Day 181+ A medicine the market moved past

[Every card for exenatide, with its sources](https://pepvault.app/peptides/exenatide#weeks)

## With this comparison

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023)
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Discontinued (Drugs@FDA)](https://pepvault.app/glossary/discontinued)
- [Open-label](https://pepvault.app/glossary/open-label)

## Questions people ask

### How long do semaglutide and exenatide last?

The half-life of semaglutide is ~1 week (FDA label). The half-life of exenatide is ~2.4 hours (FDA label).

### How often are semaglutide and exenatide taken?

Semaglutide: weekly SubQ. Route: SubQ injection. Exenatide: twice daily SubQ, before meals. Route: SubQ injection.

### How are semaglutide and exenatide dosed in research?

The FDA label range for semaglutide is 0.25–2.4 mg, with a 0.25 mg starting dose. The FDA label range for exenatide is 5–10 mcg, with a 5 mcg starting dose.

### What are the common side effects of semaglutide and exenatide?

For semaglutide, the library lists: nausea, vomiting, diarrhea, constipation, decreased appetite, fatigue, pancreatitis risk. For exenatide: nausea, vomiting, diarrhea, feeling jittery, dizziness, headache, indigestion, low blood sugar (with a sulfonylurea or insulin).

## Each one in full

- [Semaglutide: dosage, half-life & reference guide](https://pepvault.app/peptides/semaglutide)
- [Exenatide: dosage, half-life & reference guide](https://pepvault.app/peptides/exenatide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

<!--promo-->

[Track it in the app](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-next&mt=8)

<!--/promo-->

<!--promo-->

PepVault for iPhone

## Taking semaglutide or exenatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-end&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

<!--promo-->

Model. Individual results vary.

PepVault for iPhone

## Taking semaglutide or exenatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-rail&mt=8)

7 days free on the yearly plan for new subscribers.

<!--/promo-->

## With this comparison

### Semaglutide

- [Semaglutide: the full reference](https://pepvault.app/peptides/semaglutide)
- [Semaglutide dose guide](https://pepvault.app/lab/dosage/semaglutide)

### Exenatide

- [Exenatide: the full reference](https://pepvault.app/peptides/exenatide)
- [Exenatide dose guide](https://pepvault.app/lab/dosage/exenatide)

### Mixing charts

- [Semaglutide 2 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-2mg)
- [Semaglutide 5 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-5mg)
- [Semaglutide 10 mg vial](https://pepvault.app/tools/reconstitution-calculator/semaglutide-10mg)

### Studies

- [Semaglutide: 11.85% more weight loss than placebo without diabetes](https://pepvault.app/research/semaglutide-tan-2022)
- [CagriSema: 18.4% weight loss vs 11.9% on semaglutide in REDEFINE 5](https://pepvault.app/research/cagrisema-redefine-5-2026)
- [CagriSema: HbA1c down 2.33% at 40 weeks in REIMAGINE 3](https://pepvault.app/research/cagrisema-reimagine-3-2026)
- [All 31 studies](https://pepvault.app/research#semaglutide)
- [Exenatide: no cognitive benefit in mild cognitive impairment](https://pepvault.app/research/exenatide-dei-cas-2024)
- [Exenatide: lower intracranial pressure in IIH over 12 weeks](https://pepvault.app/research/exenatide-mitchell-2023)
- [Exenatide did not cut heavy drinking days in alcohol use disorder](https://pepvault.app/research/exenatide-klausen-2022)
- [All 8 studies](https://pepvault.app/research#exenatide)

### Compared with

- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

### Tools

- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [How long will my vial last?](https://pepvault.app/tools/how-long-will-my-vial-last)
- [Is my mixed vial still good?](https://pepvault.app/tools/reconstituted-peptide-expiry)
- [Half-life calculator](https://pepvault.app/tools/peptide-half-life-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)
- [GLP-1 weight loss by week](https://pepvault.app/tools/glp1-weight-loss-by-week)

### Terms on this page

- [Peptide](https://pepvault.app/glossary/peptide)
- [Receptor agonist](https://pepvault.app/glossary/receptor-agonist)
- [Subcutaneous (SubQ)](https://pepvault.app/glossary/subcutaneous)
- [Half-life](https://pepvault.app/glossary/half-life)
- [GLP-1](https://pepvault.app/glossary/glp-1)
- [Glucagon](https://pepvault.app/glossary/glucagon)
- [Discontinued (Drugs@FDA)](https://pepvault.app/glossary/discontinued)
- [Open-label](https://pepvault.app/glossary/open-label)

<!--promo-->

PepVault for iPhone

## Taking semaglutide or exenatide? Log it in PepVault

Each dose, each vial and your step-ups in one place.

[Download on the App Store](https://apps.apple.com/app/apple-store/id6779318649?pt=129020030&ct=compound-vs-card-sticky&mt=8)

7 days free on the yearly plan for new subscribers.

[Explore the live demo](https://pepvault.app/login)

<!--/promo-->

## More comparisons

- [All peptide comparisons](https://pepvault.app/peptides/compare)
- [Semaglutide vs Tirzepatide](https://pepvault.app/peptides/compare/semaglutide-vs-tirzepatide)
- [Retatrutide vs Semaglutide](https://pepvault.app/peptides/compare/retatrutide-vs-semaglutide)
- [Orforglipron vs Semaglutide](https://pepvault.app/peptides/compare/orforglipron-vs-semaglutide)
- [Cagrilintide vs Semaglutide](https://pepvault.app/peptides/compare/cagrilintide-vs-semaglutide)
- [Liraglutide vs Semaglutide](https://pepvault.app/peptides/compare/liraglutide-vs-semaglutide)
- [Semaglutide vs Dulaglutide](https://pepvault.app/peptides/compare/semaglutide-vs-dulaglutide)

## The library

- [The peptide reference library](https://pepvault.app/peptides)
- [Metabolic & GLP-1 peptides](https://pepvault.app/peptides#metabolic)

## Free tools

- [The Dose Guide](https://pepvault.app/lab/dosage)
- [Half-life & active level](https://pepvault.app/tools/peptide-half-life-calculator)
- [Reconstitution calculator](https://pepvault.app/tools/reconstitution-calculator)
- [GLP-1 titration planner](https://pepvault.app/tools/glp1-titration-calculator)

PepVault is a research and tracking resource, not medical advice. Ranges are what studies used, never a dose for you. Brand names are trademarks of their owners; PepVault is independent of them.

PepVault is a private research and tracking tool, not medical advice. The information here is reference material from published literature and community use — always verify it and discuss any protocol with a qualified clinician before changing it. Ozempic, Wegovy, Rybelsus, Mounjaro, Zepbound, Saxenda, Victoza and Trulicity are trademarks of their respective owners; PepVault is independent and not affiliated with or endorsed by any manufacturer.

© 2026 PepVault. Our text, data and tools may not be copied, scraped or republished without [permission](https://pepvault.app/terms#content).
